Analysis & Opinions
June 17, 2013
XOMA Corporation announced the initiation of a pilot study to evaluate the use of gevokizumab in acute inflammatory ...
January 02, 2013
XOMA Corporation (XOMA) recently announced that it intends to include active non-infectious anterior scleritis in ...
November 26, 2012
XOMA Corporation (XOMA) recently announced encouraging data from a phase III study PATH (Perindopril Amlodipine for ...
August 23, 2012
XOMA Corporation's (XOMA) gevokizumab recently received Orphan Drug Designation from the US Food & Drug ...
July 06, 2012
XOMA Corporation (XOMA) recently announced that it has initiated patient enrollment in two trials being conducted ...
September 02, 2011
XOMA changes management again, but should anybody care?
August 27, 2010
The fragile U.S. economy seems to be headed for the inevitable double dip, as a slew of recent data raise concerns ...